Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy.

Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy. Front Biosci (Landmark Ed). 2011 Jan 01; 16:1574-88.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.